The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013

Linda Olsson,Ingegerd Ivanov Öfverholm,Ulrika Norén-Nyström,Vasilios Zachariadis,Jessica Nordlund,Helene Sjögren,Irina Golovleva,Ann Nordgren,Kajsa Paulsson,Mats Heyman,Gisela Barbany,Bertil Johansson

The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013

2015

Linda Olsson
Ingegerd Ivanov Öfverholm
Ulrika Norén-Nyström
Vasilios Zachariadis
Jessica Nordlund
Helene Sjögren
Irina Golovleva
Ann Nordgren
Kajsa Paulsson
Mats Heyman
Gisela Barbany
Bertil Johansson

Paediatric B-cell precursor acute lymphoblastic leukaemias (BCP ALL) with IKZF1 deletions (IKZF1) are associated with a poor outcome. However, there are conflicting data as to whether IKZF1 is an i ...

Keywords:

Minimal residual disease
Diabetes mellitus
Lymphoblastic leukaemia
Medicine
Hematology
Paediatric haematology
Pediatrics
B cell
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations